UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Sells 1,058,226 Shares of Option Care Health, Inc. $OPCH

Key Points

• UBS Asset Management reduced its holdings in Option Care Health, Inc. by 40.5%, selling over 1 million shares during the first quarter, leaving it with approximately 1.55 million shares valued at $54.2 million.
• Various institutional investors, including Northwestern Mutual and Bessemer Group, significantly increased their stakes in Option Care Health, collectively enhancing their ownership of the company.
• Despite recent insider purchases, the company's stock price has experienced a drop of 3.0%, with the latest trading price at $28.48 and a consensus price target from analysts of $35.75.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 40.5% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,551,859 shares of the company's stock after selling 1,058,226 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.95% of Option Care Health worth $54,237,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in OPCH. Northwestern Mutual Wealth Management Co. lifted its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after acquiring an additional 836 shares during the last quarter. Brooklyn Investment Group lifted its stake in Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after acquiring an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio lifted its stake in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after acquiring an additional 332 shares during the last quarter. Bessemer Group Inc. lifted its stake in Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after acquiring an additional 599 shares during the last quarter. Finally, Wealthquest Corp acquired a new stake in Option Care Health in the first quarter valued at approximately $66,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The shares were acquired at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the transaction, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. The trade was a 10.61% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Norman L. Wright bought 3,411 shares of the company's stock in a transaction that occurred on Tuesday, September 9th. The shares were bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director directly owned 15,501 shares of the company's stock, valued at $454,334.31. This trade represents a 28.21% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 59,411 shares of company stock valued at $1,627,576. 0.64% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities lifted their target price on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Stock Performance

Shares of Option Care Health stock traded down $0.10 on Friday, reaching $28.31. The stock had a trading volume of 3,364,853 shares, compared to its average volume of 1,677,985. The business's 50-day moving average price is $28.83 and its two-hundred day moving average price is $31.25. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock has a market cap of $4.59 billion, a P/E ratio of 22.65, a price-to-earnings-growth ratio of 1.73 and a beta of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the firm posted $0.30 earnings per share. Option Care Health's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.